Anavex Life Sciences Corp (AVXL)

[lt2211]

You are correct. If they had a viable product, financiers would be beating a path to their door. Or they would be pursuing partners or financing. Neither is happening. Add to that, not one reputable/knowledgeable bio analyst is following the stock. These should be red flags. Instead we have a sizable group of obsessed followers, who have convinced themselves the stock is a goldmine. They literally spend day and night convincing each other of the huge profits they will make. This obsession has led to over investment, in a highly risky stock. The future could be bleak for many.